Latest Securities Issuance News

Challenger Limited has announced a fully franked dividend totaling AUD 0.175 per share for the six months ending 30 June 2026, including an ordinary dividend of AUD 0.16 and a special dividend of AUD 0.015. Shareholders can opt into a Dividend Reinvestment Plan with no discount, using a VWAP-based price.

Microba Life Sciences has wrapped up a $5.41 million capital raise combining a $5 million institutional Placement and a $407,500 Share Purchase Plan, strengthening its balance sheet to accelerate growth in Australia and the UK.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

Hydrix Limited has secured $5.22 million from its retail entitlement offer, leaving nearly $3 million in entitlements unsold, which will be offered separately under a shortfall offer managed by Peak Asset Management.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Complii FinTech Solutions has landed a strategic two-year deal with a major financial institution, marking its entry into the institutional market segment and positioning the company for scalable growth in capital raising software services.

ColCap Financial Limited (ASX:TT6) reported a 16% rise in net profit to $72.2 million for FY2025, driven by a 15% expansion in its loan portfolio to $19.3 billion and a series of record Residential Mortgage-Backed Securities issuances.

African Gold Ltd has finalised its court-approved scheme of arrangement, transferring all shares and options to Montage Gold Corp and preparing for imminent ASX delisting.

NT Minerals Limited aims to raise up to $968,722 through a pro-rata entitlement offer and complete the acquisition of Slipstream Paynes Find, a move critical to meeting ASX reinstatement conditions and funding exploration in Western Australia.

Wisr Limited reports robust half-year growth with a 23% increase in its loan book and a 14% rise in revenue, setting the stage for expected cash profitability in the second half of FY26.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

AuMEGA Metals has launched a C$10 million private placement to fund an extensive drilling program targeting high-potential gold and base metal prospects in Newfoundland’s Cape Ray District. The financing aims to unlock value from its significant mineral resources and strategic landholdings.